
| Pair Name | Genipin, Everolimus | ||
| Phytochemical Name | Genipin (PubChem CID: 442424 ) | ||
| Anticancer drug Name | Everolimus (PubChem CID: 6442177 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Genipin, Everolimus | |||
| Disease Info | [ICD-11: 2C10.Z] | Pancreatic cancer | Investigative | |
| Biological Phenomena | Induction-->Proliferation | |||
| Gene Regulation | Up-regulation | Expression | BECN1 | hsa8678 |
| Up-regulation | Expression | UCP2 | hsa7351 | |
| Up-regulation | Expression | MTOR | hsa2475 | |
| Up-regulation | Expression | AKT1 | hsa207 | |
| Up-regulation | Expression | ROS1 | hsa6098 | |
| In Vitro Model | PaCa-44 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_7087 |
| PaCa-3 | Pancreatic carcinoma | Homo sapiens (Human) | CVCL_4011 | |
| PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 | |
| MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 | |
| T3M-4 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_4056 | |
| In Vivo Model | PaCa44 cells (1×10⁶ cells/mice) were s.c. injected into the dorsal flank of six nude female mice for each condition (5 weeks of age; Charles River Laboratories, Inc.). | |||
| Result | These results reveal novel mechanisms through which UCP2 promotes cancer cell proliferation and support the combined inhibition of UCP2 and of Akt/mTOR pathway as a novel therapeutic strategy in the treatment of pancreatic adenocarcinoma. | |||
| No. | Title | Href |
|---|---|---|
| 1 | UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism. Free Radic Biol Med. 2017 Dec;113:176-189. doi: 10.1016/j.freeradbiomed.2017.09.022. | Click |